Cardiac function is regulated by the sodium-dependent inhibition of the sodium-calcium exchanger NCX1.
Kyle ScrantonScott JohnMarina AngeliniFederica SteccanellaSoban UmarRui ZhangJoshua I GoldhaberRiccardo OlceseMichela OttoliaPublished in: Nature communications (2024)
The Na + -Ca 2+ exchanger (NCX1) is the dominant Ca 2+ extrusion mechanism in cardiac myocytes. NCX1 activity is inhibited by intracellular Na + via a process known as Na + -dependent inactivation. A central question is whether this inactivation plays a physiological role in heart function. Using CRISPR/Cas9, we inserted the K229Q mutation in the gene (Slc8a1) encoding for NCX1. This mutation removes the Na + -dependent inactivation while preserving transport properties and other allosteric regulations. NCX1 mRNA levels, protein expression, and protein localization are unchanged in K229Q male mice. However, they exhibit reduced left ventricular ejection fraction and fractional shortening, while displaying a prolonged QT interval. K229Q ventricular myocytes show enhanced NCX1 activity, resulting in action potential prolongation, higher incidence of aberrant action potentials, a faster decline of Ca 2+ transients, and depressed cell shortening. The results demonstrate that NCX1 Na + -dependent inactivation plays an essential role in heart function by affecting both cardiac excitability and contractility.
Keyphrases
- left ventricular
- ejection fraction
- heart failure
- crispr cas
- aortic stenosis
- small molecule
- acute myocardial infarction
- atrial fibrillation
- protein kinase
- risk factors
- dna methylation
- hypertrophic cardiomyopathy
- genome wide
- single cell
- left atrial
- drug induced
- stem cells
- coronary artery disease
- gene expression
- binding protein
- cell therapy
- percutaneous coronary intervention
- transcranial direct current stimulation
- human health
- risk assessment
- catheter ablation
- reactive oxygen species